Beginning at present, Dexcom G7 steady glucose monitor (CGM) customers will be capable of monitor their real-time blood sugar information straight from an Apple Watch.
In keeping with Dexcom’s press launch, the Direct to Apple Watch characteristic was probably the most requested by customers. As soon as paired to the Apple Watch, the G7 will use its personal devoted Bluetooth connection to ship each glucose readings and customized alerts to the wrist. That means, you don’t must whip out your cellphone if you wish to view your information, nor does your cellphone have to be in your particular person. As an example, G7 customers will nonetheless be capable of get real-time information whereas on a phone-free run / stroll or in case your cellphone is charging in a distinct room. Beforehand, the G7’s Apple Watch app allowed you to have a watchface complication, however there was a three-hour delay with synced information.
That is extra of a secondary strategy to view information and obtain alerts, not a substitute on your smartphone or Dexcom receiver. You continue to want a appropriate iPhone to initially arrange the G7 CGM and pair it with the Apple Watch. Sharing information with household and mates additionally requires your cellphone to be inside 20 ft of vary. You’ll additionally want your cellphone in order for you a extra holistic view of your blood glucose information alongside different metrics (e.g., exercise, menstrual cycles, sleep, and so forth.) within the Apple Well being app.
At launch, the Direct to Apple Watch characteristic will likely be out there within the US, UK, and Eire. The characteristic will roll out to extra markets later this month, although Dexcom didn’t specify precisely which. Of us within the characteristic ought to replace the Dexcom G7 app to model 2.1 and can want no less than an Apple Watch Collection 6 working watchOS 10 or later. They have to even have an iPhone working iOS 17 or later.
It’s essential to notice that this characteristic is extra a step in making present CGMs extra handy to make use of, quite than making smartwatches a standalone, non-invasive blood glucose monitoring software. (Whereas many corporations are actively investing that tech, it’s nonetheless not going we’ll see it anytime quickly.) Alongside that vein, Dexcom additionally just lately introduced it acquired FDA clearance for the Stelo CGM, an over-the-counter machine geared towards non-insulin dependent, Sort 2 diabetes sufferers. The Stelo, which was launched at CES 2024, is predicted to be out there later this summer season.
